Aerospace and Defense

Arxis

Arxis to Release FY2026 Q1 Earnings on May 27 After-Market EST, Forecast Revenue USD 422.65 M, EPS USD 0.1225

William Blair Analyst Gives Arxis a Buy Rating

Arxis CFO Buys Company Shares

Arxis CEO Ross Sealfon Increases Holdings to 1,102,807 Shares

Arxis Director Purchases 15,357 Shares of Class A Common Stock

Arxis CEO Kevin Perhamus Acquires Shares Through IPO Directed Share Plan

Arxis CEO Jason Roth Buys Company Stocks

Arxis, Inc. released FY2025 earnings on March 24 (EST), actual revenue USD 1.591 B, actual EPS USD 0

Arxis, Inc. released FY2023 earnings on March 24 (EST) with actual revenue of USD 424.5 M and EPS of USD 0

Arxis, Inc. released FY2024 Annual Earnings on March 24, 2026 (EST) with actual revenue of USD 742.99 M and EPS of USD 0

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Earning Release Date

财报预告

FY2026 Q1 Earning Release 2026.05.27 (EST) After-Market

ARXS

Two financial analysts on Wall Street have started covering Arxis, a recently listed aerospace firm, with a positive outlook. Following the release of the favorable ratings, Arxis experienced an 8% increase on Monday. Multiple analysts have begun coverage of this aerospace initial public offering (IPO) with a "buy" rating.

Unusual Whales

Multiple Analysts Initiate This Aerospace IPO At Buy Rating

LOKV

MAIR

BBOT

OKLO

Top Wall Street analysts have initiated coverage on several companies with varying ratings and price targets. Goldman Sachs analyst Noah Poponak rated Arxis Inc (NASDAQ:ARXS) as Buy with a price target of $53. Other notable initiations include Madison Air Solutions (NYSE:MAIR) with an Outperform rating and a $48 target, BridgeBio Oncology (NASDAQ:BBOT) with a Buy rating and a $23 target, Live Oak Acquisition (NASDAQ:LOKV) with a Buy rating and a $13.5 target, and Oklo Inc (NYSE:OKLO) with a Neutral rating and an $83 target.

benzinga_article

Live Oak Acquisition Corp V

Madison Air Solutions

BridgeBio Oncology Therapeutics

Oklo

Live Oak Acquisition Corp V - Unit

LIVE OAK ACQUISITION CORP V C/WTS (TO PUR COM)

This Arxis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Melius Research has initiated coverage on Arxis (NASDAQ:ARXS), assigning a "buy" rating and a price target of $45.00, indicating a potential upside of 28.21%. Other firms, including Morgan Stanley and Citigroup, have also issued positive ratings. Currently, Arxis has a consensus rating of "Moderate Buy" with a target of $45.27. The stock opened at $35.10, with a 1-year range of $34.44 to $39.45. Recent insider purchases have increased their holdings significantly, reflecting confidence in the company's prospects.

Market Beat

Morgan Stanley

Citigroup

Goldman Sachs

Apple

Tapestry

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

Arxis (NASDAQ:ARXS) Now Covered by Analysts at Melius Research

Arxis, Inc. (ARXS) has been initiated with a Buy rating by William Blair analyst Louie DiPalma, citing its diversified platform across defense, aerospace, and industrial sectors. The company boasts over 600 platforms and 5,000 customers, supporting resilient revenue growth. DiPalma notes Arxis's strong EBITDA margins and potential for further expansion, driven by strategic acquisitions and operational tools. He sees over 20% upside potential for the stock, despite risks from aerospace cyclicality and defense budget fluctuations. Robert W. Baird also initiated coverage with a Buy rating and a $55 price target.

- Arxis, Inc. (ARXS) has received a new buy rating from William Blair analyst Louie DiPalma, highlighting its strong growth prospects.  
- DiPalma cites Arxis's diversification across over 600 defense and aerospace platforms, a broad customer base, and increased demand visibility in critical sectors, projecting EBITDA margins to rise from 20% to 30%.  
- The stock is currently trading at a moderate discount on forward EBITDA, with DiPalma anticipating over 20% potential upside, despite acknowledging risks from cyclical aerospace factors and potential defense budget adjustments.

Tip Ranks

Arxis Initiated at Buy on Diversified Defense & Industrial Platform, Expanding Margins, and 20%+ Upside Potential

Rothschild & Co Redburn analyst Margaret Schooley has initiated coverage of Arxis, Inc. Class A (ARXS) with a Buy rating and a price target of $40.00. Goldman Sachs also gave the stock a Buy rating, setting a higher price target of $53.00. Schooley has a 4-star rating with an average return of 23.6% and a success rate of 76.47%.

Arxis, Inc. Class A (ARXS) Receives a Buy from Rothschild & Co Redburn

SPIR

ARKX

This month, three undervalued space stocks are highlighted: Redwire (NYSE: RDW), Spire Global (NYSE: SPIR), and Arxis (NASDAQ: ARXS). Redwire, with a price-to-sales ratio of 5.8x, offers a diversified portfolio essential for space infrastructure. Spire, valued below 9x sales, is stabilizing after selling its maritime data business, projecting revenue growth by 2028. Arxis, a recent IPO, raised $1.1 billion and has a market cap of $15.2 billion, trading at 9.5x sales. These stocks present potential investment opportunities in the growing space sector.

nasdaq

Redwire

Spire Global

Invesco Aero & Defense ETF

ARK Space Exploration & Innovation ETF

Firefly Aerospace

Rocket Lab

NVIDIA

Intel

NVIDIA Corporation

3 Space Stocks Flying Under the Radar and Worth Buying This Month

AVEX

SWMR

Military drone manufacturer Aevex Corp. has seen its shares double in value within two trading sessions, rising from an IPO price of $20 to $40.25, amid a surge in defense technology IPOs. This trend is fueled by increased military spending due to global conflicts, particularly the use of drones. Other defense firms like Arxis Inc. and Swarmer Inc. have also experienced significant stock price increases. Analysts suggest that despite some investor caution, there is strong interest in innovative defense technologies in the current geopolitical climate.

Arxis(ARXS.US)